Searched for
GLENMARK LIFE OFS
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- Stocks in news: Nykaa, TCS, Tata Elxsi, Glenmark Life, YES Bank, SiemensMarkets fell half a percent. TCS, Tata Elxsi, Anand Rathi Wealth, and Akme Fintrade Q1 results are in focus. Canada Pension Plan sold Nykaa...
- Promoters to sell 7.85% in Glenmark Life through OFSThe OFS will be open for non-retail investors on Thursday, with retail investors allowed to place their bids on Friday. A minimum of 10% of...
- Glenmark Pharma to sell 7.84% stake in Glenmark Life via OFSThe stake sale will be done through the stock exchanges via an offer for sale (OFS). The decision was made at a meeting held today, and the...
- F&O stocks: SBI Life, Glenmark Pharma among 5 stocks with short buildupSBI Life, Glenmark Pharma, and IOC were among the 5 stocks with a buildup of fresh short positions. Friday's trading session saw these stoc...
- Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitisGlenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has rec...
- Fundamental Radar: Why is Beta Drugs a good play in the oncology space? Sandeep Raina explainsBeta Drugs is well placed to capitalise on the growth opportunities in the oncology drugs segment, aided by its comprehensive product portf...
- F&O stocks: IEX, BHEL and 3 other stocks with short buildupComing to the buildup of fresh short positions, When the stock prices move downward and open interest on the counter increases, it is taken...
- Stocks in news: ITC, Campus Activewear, LIC, Bharat Electronics, HAL, VedantaThe diversified conglomerate is going for climate-risk modelling to identify the hotspots owing to extreme weather conditions, Chairman San...
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...
- IPO listing scorecard in August: 5 winners and 5 losersEuphoric performance of IPOs during 2020 and in the first eight months of this year also had its fallout. Oversupply, fall in quality, and ...
- 5 pharma/healthcare IPOs to raise over Rs 8,000 cr this monthAccording to data available with the stock exchanges, so far this fiscal, 12 firms have raised Rs 27,000 crore from IPOs, and Rs 70,000-cro...
- Glenmark Life IPO opens next week; dates, price band announcedAt the higher end of the price band, the company is expected to raise Rs 1,513.6 crore via its initial shale sale. The promoter holds 100 p...
- Two IPOs to hit market next week; to raise over Rs 2,500 cr cumulativelyThis comes after five companies Shyam Metalics and Energy, Sona BLW Precision Forgings (Sona Comstar), Krishna Institute of Medical Science...
- Healthcare cos see a Covid lining, line up to raise record moneyAt least 12 drug makers and healthcare companies are planning IPOs in 2021 as the pandemic increases investor demand for the promising play...
- Mega diabetes drug to be cheaper soonWith Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.
- After Market: Tyre stocks jump; IFCI surges 18%; 92 stocks now oversoldSensex jumped 312 points, or 0.80% while Nifty ended 97 points, or 0.83%, higher.
- 15 companies to pay higher dividend: ReportIn a report released today, IiAS said that companies have been hoarding cash and this has plagued corporate India for long.
- PNB has come out of the woods in terms of asset quality: Sudip BandyopadhyayGovernment has woken up to the idea of proper positioning, pricing of disinvestment candidates, says Sudip Bandyopadhyay.
- Indian cos eye $4bn generic opportunityExperts feel that after allowing 90% price erosion once generic drug versions appear in the market, and due to intense competition, the act...
Load More
